Clinical Trial

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Study acronym: TRACKLESS
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 5, 2026 (before its estimated April 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
With this project, the research team aims to identify the molecular pathways associated with the response to extracorporeal photonchemioapheresis (ECP) in kidney or lung transplant patients suffering from chronic rejection, by analyzing gene expression in samples of peripheral blood mononuclear cells.
Trial Details
NCT Number NCT07316829
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions Graft Rejection, Kidney Transplantation, Lung Transplantation, Antibody-Mediated Rejection, Chronic Disease, Bronchiolitis Obliterans, HLA Antibodies, Antibodies, Donor-Specific +1 more
Enrollment 30 participants
Start Date 2025-04-10
Primary Completion 2026-04-10 (estimated)
Study Completion 2026-04-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-05